Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile dysfunction in diabetic patients].

A Lemaire1, B Alexandre

  • 1Endocrinologue sexologue, Lille.

Presse Medicale (Paris, France : 1983)
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Transplantation Timing on Renal Graft Survival Outcomes and Perioperative Complications.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same author

La Revue de medecine interne·2020
Same author

Hemoperitoneum in peripartum: A case-series.

Journal of neonatal-perinatal medicine·2017
Same author

Is the adjustable transobturator system ATOMS® useful for the treatment of male urinary incontinence in low to medium volume urological centers?

Actas urologicas espanolas·2017
Same author

[Visceral larva migrans with cardiac manifestation: a case report and literature review].

La Revue de medecine interne·2013
Same author

Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review.

Andrologia·2013
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Erectile dysfunction (ED) affects 66% of diabetic patients, with 77% desiring treatment. Screening and appropriate management, starting with oral medications and progressing to injections if needed, are crucial for improving patient outcomes.

Area of Science:

  • Endocrinology
  • Urology
  • Diabetology

Background:

  • Erectile dysfunction (ED) is highly prevalent in diabetic patients.
  • It significantly impacts quality of life, with a majority desiring treatment.
  • Physiopathology involves diabetes-related vascular and neurological complications.

Purpose of the Study:

  • To highlight the necessity of systematic ED screening in diabetic individuals.
  • To outline current treatment strategies for ED in this population.
  • To emphasize the importance of timely and effective management of ED.

Main Methods:

  • Analysis of survey data from ADIRS-AFD regarding ED prevalence and patient desires.
  • Review of physiopathological links between diabetes and ED.

Related Experiment Videos

  • Evaluation of treatment efficacy and safety profiles.

    • Main Results:

    • ED affects 66% of surveyed diabetic patients, with a mean duration of 6 years.
    • 77% of affected patients expressed a desire for treatment.
    • First-line treatment with oral phosphodiesterase type 5 inhibitors (iPDE5) may have reduced efficacy and contraindications in diabetics.

    Conclusions:

    • Systematic screening for ED in diabetic patients is essential due to its high frequency.
    • Intracavernous prostaglandin E1 (PGE1) injections offer an efficient and safe second-line treatment option.
    • Specialized consultation is reserved for cases unresponsive to initial treatments.